John Lawrence Wallace - Net Worth and Insider Trading
John Lawrence Wallace Net Worth
The estimated net worth of John Lawrence Wallace is at least $449,278 dollars as of 2024-11-08. John Lawrence Wallace is the Director, Director or Senior Officer of 10% Securi of Antibe Therapeutics Inc and owns about 1,522,976 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $449,278. Details can be seen in John Lawrence Wallace's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Lawrence Wallace has not made any transactions after 2022-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Lawrence Wallace
John Lawrence Wallace Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Lawrence Wallace owns 1 companies in total, including Antibe Therapeutics Inc (TSX:ATE) .
Click here to see the complete history of John Lawrence Wallace’s form 4 insider trades.
Insider Ownership Summary of John Lawrence Wallace
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:ATE | Antibe Therapeutics Inc | 2022-12-13 | Director & Director or Senior Officer of 10% Security Holder & Senior Officer |
John Lawrence Wallace Latest Holdings Summary
John Lawrence Wallace currently owns a total of 1 stock. John Lawrence Wallace owns 1,522,976 shares of Antibe Therapeutics Inc (TSX:ATE) as of December 13, 2022, with a value of $449,278.
Latest Holdings of John Lawrence Wallace
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:ATE | Antibe Therapeutics Inc | 2022-12-13 | 1,522,976 | 0.30 | 449,278 |
Holding Weightings of John Lawrence Wallace
John Lawrence Wallace Form 4 Trading Tracker
According to the SEC Form 4 filings, John Lawrence Wallace has made a total of 11 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 4 buys and 7 sells. The most-recent trade in Antibe Therapeutics Inc is the sale of 91,000 shares on December 13, 2022, which brought John Lawrence Wallace around $44,590.
Insider Trading History of John Lawrence Wallace
- 1
John Lawrence Wallace Trading Performance
GuruFocus tracks the stock performance after each of John Lawrence Wallace's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Lawrence Wallace is -14.67%. GuruFocus also compares John Lawrence Wallace's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Lawrence Wallace within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Lawrence Wallace's insider trading performs compared to the benchmark.
Performance of John Lawrence Wallace
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.78 | | | | | |
| Relative Return to S&P 500(%) | -10.71 | | | | | |
John Lawrence Wallace Ownership Network
Ownership Network List of John Lawrence Wallace
Ownership Network Relation of John Lawrence Wallace
John Lawrence Wallace Owned Company Details
What does Antibe Therapeutics Inc do?
Who are the key executives at Antibe Therapeutics Inc?
John Lawrence Wallace is the Director & Director or Senior Officer of 10% Security Holder & Senior Officer of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Senior Officer Joseph Stauffer , Senior Officer Scott Wilson Curtis , and Senior Officer Daniel Marcel Legault .
Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antibe Therapeutics Inc Insider Transactions
John Lawrence Wallace Mailing Address
Above is the net worth, insider trading, and ownership report for John Lawrence Wallace. Currently GuruFocus does not have mailing address information for John Lawrence Wallace.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
